Search for: "Noonan, in Re"
Results 1 - 20
of 285
Sort by Relevance
|
Sort by Date
12 Mar 2024, 9:13 pm
Noonan -- Last week, the Federal Circuit handed down its opinion in Pfizer Inc. v. [read post]
26 Feb 2024, 9:50 pm
Noonan -- The Federal Circuit's In re Cellect decision has caused a great deal of commentary and proposals to avoid its consequences, including changing prosecution strategies and filing prospective, precautionary terminal disclaimers (see "Overcoming the Consequences of In re Cellect") to reimbue predictability regarding patent term to patent portfolio prosecution (as well as there being a pending certiorari petition before the Supreme Court). [read post]
22 Jan 2024, 1:16 pm
The Fate of Patent Term Adjustment: In re Cellect Seeks Rehearing on Double Patenting Parties Cellect, LLC: Paul J. [read post]
11 Jan 2024, 9:31 pm
Noonan -- On January 10th, the U.S. [read post]
2 Jan 2024, 8:45 pm
Cir. 2023)*In re Institut Pasteur (Fed. [read post]
18 Dec 2023, 9:07 pm
Cir. 2023)In re Institut Pasteur (Fed. [read post]
13 Dec 2023, 8:25 pm
Noonan -- In the shadow of its recent, precedent-challenging In re Cellect decision, the Federal Circuit illustrated the pedestrian application of its obviousness-type double patenting jurisprudence in affirming the Patent Trial and Appeal Board's rejection on ODP grounds in In re Institut Pasteur. [read post]
27 Nov 2023, 9:10 pm
Cir. 2023)In re Theripion (Fed. [read post]
5 Oct 2023, 9:11 pm
Related StoriesIn re Cellect (Fed. [read post]
24 Sep 2023, 9:59 pm
Cir. 2023)Judge Newman Suspended for One Year by Federal CircuitIn re Cellect (Fed. [read post]
20 Sep 2023, 9:18 am
Cir. 2023)In re Cellect (Fed. [read post]
17 Sep 2023, 9:17 pm
Cir. 2023)In re Theripion (Fed. [read post]
6 Sep 2023, 5:58 am
“Electra and team have created a globally recognized standard in oneNDA and we’re absolutely honored to power the software that automates it,” he said. [read post]
30 Aug 2023, 7:42 pm
Noonan -- The Federal Circuit decided a question left open during a recent spate of opinions involving the judicially created doctrine of obviousness-type double patenting (ODP): the effect patent term adjustment (PTA) can (or should) have on creating circumstances where ODP will operate to find a patent invalid in the absence of a timely filed terminal disclaimer, in its opinion handed down yesterday in In re Cellect. [read post]
10 Aug 2023, 8:47 pm
Noonan -- The Patent Trial and Appeal Board (PTAB) has benefited, particularly after enactment of the Leahy-Smith America Invents Act, from the deference to its factual findings mandated by the Supreme Court's interpretation in Dickenson v. [read post]
27 Jul 2023, 9:20 pm
Noonan -- In earlier times, the Federal Circuit, responding to efforts by the U.S. [read post]
27 Jun 2023, 7:32 pm
Noonan -- The Federal Circuit provided a reminder last week that merely identifying an unappreciated consequence of a prior art method cannot confer non-obviousness on practice of methods that did not acknowledge that consequence, in In re Couvaras. [read post]
27 Jun 2023, 7:32 pm
Noonan -- The Federal Circuit provided a reminder last week that merely identifying an unappreciated consequence of a prior art method cannot confer non-obviousness on practice of methods that did not acknowledge that consequence, in In re Couvaras. [read post]
7 Mar 2023, 9:16 pm
Noonan -- The Supreme Court's (re)consideration of the enablement requirement expected in its decision later this year in Amgen v. [read post]
13 Feb 2023, 9:12 pm
Noonan -- A change in the weather is known to be extreme But what's the sense of changing horses in midstream? [read post]
